A detailed history of Salem Capital Management Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Salem Capital Management Inc holds 81,739 shares of MRK stock, worth $9.63 Million. This represents 5.57% of its overall portfolio holdings.

Number of Shares
81,739
Previous 81,605 0.16%
Holding current value
$9.63 Million
Previous $7.44 Million 5.39%
% of portfolio
5.57%
Previous 5.42%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 29, 2022

BUY
$84.53 - $94.96 $11,327 - $12,724
134 Added 0.16%
81,739 $7.04 Million
Q2 2022

Jul 27, 2022

SELL
$83.49 - $94.64 $448,007 - $507,838
-5,366 Reduced 6.17%
81,605 $7.44 Million
Q1 2022

Apr 07, 2022

SELL
$73.51 - $82.4 $55,132 - $61,800
-750 Reduced 0.85%
86,971 $7.14 Million
Q4 2021

Jan 18, 2022

SELL
$72.28 - $90.54 $68,666 - $86,013
-950 Reduced 1.07%
87,721 $6.72 Million
Q3 2021

Oct 12, 2021

SELL
$71.68 - $78.83 $129,024 - $141,894
-1,800 Reduced 1.99%
88,671 $6.66 Million
Q2 2021

Jul 13, 2021

BUY
$70.31 - $77.77 $235,538 - $260,529
3,350 Added 3.85%
90,471 $7.04 Million
Q1 2021

Apr 15, 2021

BUY
$68.86 - $81.11 $473,412 - $557,631
6,875 Added 8.57%
87,121 $6.72 Million
Q4 2020

Jan 12, 2021

SELL
$71.77 - $79.65 $77,511 - $86,022
-1,080 Reduced 1.33%
80,246 $6.56 Million
Q3 2020

Oct 13, 2020

SELL
$73.18 - $82.95 $307,795 - $348,887
-4,206 Reduced 4.92%
81,326 $6.75 Million
Q2 2020

Jul 20, 2020

SELL
$70.42 - $80.13 $4,225 - $4,807
-60 Reduced 0.07%
85,532 $6.61 Million
Q1 2020

Apr 14, 2020

SELL
$63.36 - $87.82 $427,680 - $592,785
-6,750 Reduced 7.31%
85,592 $6.59 Million
Q4 2019

Jan 09, 2020

SELL
$77.58 - $87.54 $178,434 - $201,342
-2,300 Reduced 2.43%
92,342 $8.4 Million
Q3 2019

Oct 07, 2019

SELL
$76.08 - $82.93 $538,266 - $586,729
-7,075 Reduced 6.96%
94,642 $7.97 Million
Q2 2019

Jul 09, 2019

SELL
$69.84 - $81.59 $380,628 - $444,665
-5,450 Reduced 5.09%
101,717 $8.53 Million
Q1 2019

Apr 15, 2019

SELL
$69.58 - $79.36 $209,366 - $238,794
-3,009 Reduced 2.73%
107,167 $8.91 Million
Q4 2018

Jan 08, 2019

SELL
$65.24 - $75.71 $47,038 - $54,586
-721 Reduced 0.65%
110,176 $8.42 Million
Q3 2018

Oct 09, 2018

SELL
$57.69 - $67.84 $115,206 - $135,476
-1,997 Reduced 1.77%
110,897 $7.87 Million
Q2 2018

Jul 09, 2018

SELL
$50.83 - $59.72 $30,498 - $35,832
-600 Reduced 0.53%
112,894 $6.85 Million
Q1 2018

Apr 09, 2018

BUY
$50.96 - $59.23 $54,782 - $63,672
1,075 Added 0.96%
113,494 $6.18 Million
Q4 2017

Jan 16, 2018

SELL
$51.62 - $61.64 $101,433 - $121,122
-1,965 Reduced 1.72%
112,419 $6.33 Million
Q3 2017

Oct 10, 2017

BUY
$58.67 - $63.13 $6.71 Million - $7.22 Million
114,384
114,384 $7.32 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $299B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Salem Capital Management Inc Portfolio

Follow Salem Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.